Photos by Kyle LaHucik
August 30, 2022 06:19 AM EDTUpdated September 1, 10:59 AM
People
R&D

#ESC22: In re­turn to ‘big chron­ic dis­eases,’ Eu­rope’s car­dio con­fab show­cas­es mixed bag of da­ta drops

Kyle LaHucik

Senior Reporter

BARCELONA — For the first time dur­ing Covid-19, 30,000 car­di­ol­o­gists, bio­phar­ma lead­ers and tri­al in­ves­ti­ga­tors met in per­son for the Eu­ro­pean So­ci­ety of Car­di­ol­o­gy Con­gress. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times